Paclitaxel Polymeric Micelles nyefe teknụzụ

Nkọwa dị mkpirikpi:

Paclitaxel Polymeric Micelles bụ nkwadebe ọhụrụ nke taxol, nkà na ụzụ ọhụrụ na-ejikọta nanotechnology na biomedical polymer material synthesis technology. Nke a na-emepụta nwere ike dị ukwuu na vivo nkwụsi ike na mmetụta dị elu nke ntọhapụ ọgwụ na tumor. micelles nwere nchekwa dịtụ mma ma ọ bụrụ na usoro onunu ogwu na-abawanye nke ukwuu, ọ nweghịkwa pretreatment mgbochi nrịanrịa achọrọ tupu ejiri ya.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Uru nke paclitaxel polymer micelles

1.Copolymer na-agbakọta onwe ya na mmiri iji mepụta nanocarrier nke nwere "isi-shell" structure. The nuclear encapsulated paclitaxel of the micelle adịghị emebi emebi, ka o wee nwee ike ịrụ ọrụ n'ọbara ruo ogologo oge.

2.The polymer micellar paclitaxel particles dị nnọọ obere (18-20nm), nke nwere ike passively ezubere iche n'ime tumor microenvironment na vaskụla ọrịa. Akpụkpọ anụ ahụ na obere ntinye uche na anụ ahụ nkịtị. Mgbe ọ na-eme ka ọ dị irè, a na-ebelata mmetụta nke mmetụta ndị ọzọ.

Ọrụ Nyefe teknụzụ Hande

Yunnan Hande Biotechnology Co., Ltd bụ ọkachamara na mmepụta nke paclitaxel API ihe karịrị afọ 20, na ọ bụ otu n'ime ụwa nwere onwe ya na-emepụta paclitaxel API, a osisi sitere na ọgwụ cancer na-enweta, nke US FDA, European kwadoro. EDQM, Australian TGA, Chinese CFDA, India, Japan na ndị ọzọ mba regulatory agency.Hande nwere ike inye ọ bụghị naanị elu-edu paclitaxel akụrụngwa, kamakwa teknuzu kwalite ọrụ metụtara paclitaxel formulation. Maka ozi ọzọ, biko chere free ịkpọtụrụ anyị na 18187887160.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: